Zheng Yan, Gao Xiang, Jia Hai-Yi, Li Fu-Rong, Ye Hui
The Fourth Affiliated Hospital Zhejiang University School of Medicine, Zhejiang, China.
School of Public Health, Shanghai Jiao Tong University, Shanghai, China.
Front Cardiovasc Med. 2022 Oct 17;9:948707. doi: 10.3389/fcvm.2022.948707. eCollection 2022.
A longer duration of hypertension (HTN) has been suggested to be associated with a greater risk of cardiovascular disease (CVD). Whether such an association is similar for mortality risk, and whether HTN duration is associated with CVD/mortality beyond blood pressure (BP) control levels are yet to be assessed. We aimed to examine the associations of HTN duration and the combination of HTN duration and systolic blood pressure (SBP)/diastolic blood pressure (DBP) with risks of CVD and all-cause mortality.
We used data on ∼450,000 UK residents. Participants were categorized by HTN status and HTN duration. The primary outcome was a composite of non-fatal myocardial infarction, non-fatal stroke and CVD death. We also explored the results for the above-mentioned CVD outcomes separately. All-cause mortality was also used as a secondary outcome. The age at HTN diagnosis was obtained by self-report. HTN duration was calculated as baseline age minus age at diagnosis.
Among all participants, compared with non-hypertensive participants, those with a longer HTN duration had increased risks of CVD and all-cause mortality. These associations persisted among hypertensive patients. Specifically, compared with patients with HTN durations of < 5 y, patients with a HTN duration of 5 to < 10 y, 10 to < 15 y, and ≥ 15 y had adjusted HRs (95% CI) of 1.09 (1.03, 1.17), 1.21 (1.13, 1.31), and 1.38 (1.29, 1.48) for composite CVD (-trend < 0.001); and 1.03 (0.97, 1.08), 1.09 (1.02, 1.16), and 1.17 (1.11, 1.24) for all-cause mortality (-trend < 0.001). When compared with hypertensive patients with BP < 140/90 mmHg and a HTN duration of < 5 y, adjusted HRs of CVD and all-cause mortality were 1.35 (1.15, 1.57) and 1.26 (1.11, 1.42) for those with BP < 140/90 mmHg and a duration of ≥ 15 y, and 1.43 (1.26, 1.60) and 1.13 (1.03, 1.25) for those with BP ≥ 140/90 mmHg and durations of ≥ 15 y, respectively.
A longer HTN duration was associated with increased risks of CVD and overall death in a linear fashion, and these associations were independent of BP control levels.
有研究表明,高血压(HTN)病程较长与心血管疾病(CVD)风险较高相关。这种关联在死亡风险方面是否相似,以及高血压病程是否独立于血压(BP)控制水平与心血管疾病/死亡相关,仍有待评估。我们旨在研究高血压病程以及高血压病程与收缩压(SBP)/舒张压(DBP)的组合与心血管疾病风险和全因死亡率之间的关联。
我们使用了约45万英国居民的数据。参与者按高血压状态和高血压病程进行分类。主要结局为非致死性心肌梗死、非致死性卒中和心血管疾病死亡的复合结局。我们还分别探讨了上述心血管疾病结局的结果。全因死亡率也用作次要结局。高血压诊断年龄通过自我报告获得。高血压病程计算为基线年龄减去诊断年龄。
在所有参与者中,与非高血压参与者相比,高血压病程较长者患心血管疾病和全因死亡的风险增加。这些关联在高血压患者中持续存在。具体而言,与高血压病程<5年的患者相比,高血压病程为5至<10年、10至<15年和≥15年的患者,复合心血管疾病的调整后风险比(HR)(95%置信区间)分别为1.09(1.03,1.17)、1.21(1.13,1.31)和1.38(1.29,1.48)(-趋势<0.001);全因死亡率的调整后HR分别为1.03(0.97,1.08)、1.09(1.02,1.16)和1.17(1.11,1.24)(-趋势<0.001)。与血压<140/90 mmHg且高血压病程<5年的高血压患者相比,血压<140/90 mmHg且病程≥15年的患者心血管疾病和全因死亡的调整后HR分别为1.35(1.15,1.57)和1.26(1.11,1.42),血压≥140/90 mmHg且病程≥15年的患者分别为1.43(1.26,1.60)和1.13(1.03,1.25)。
高血压病程较长与心血管疾病风险和总体死亡风险呈线性增加相关,且这些关联独立于血压控制水平。